Literature DB >> 32981958

Coagulopathy Characterized by Rotational Thromboelastometry in a Porcine Pediatric ECMO Model.

Christopher R Reed1, Desiree Bonadonna1, Jeffrey Everitt1, Victoria Robinson1, James Otto1, Elisabeth T Tracy1.   

Abstract

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used to support patients with reversible cardiopulmonary insufficiency. Although it is a lifesaving technology, bleeding, inflammation, and thrombosis are well-described complications of ECMO. Adult porcine models of ECMO have been used to recapitulate the physiology and hemostatic consequences of ECMO cannulation in adults. However, these models lack the unique physiology and persistence of fetal forms of coagulation factors and fibrinogen as in human infants. We aimed to describe physiologic and coagulation parameters of piglets cannulated and supported with VA-ECMO. Four healthy piglets (5.7-6.4 kg) were cannulated via jugular vein and carotid artery by cutdown and supported for a maximum of 20 hours. Heparin was used with a goal activated clotting time of 180-220 seconds. Arterial blood gas (ABG) was performed hourly, and blood was transfused from an adult donor to maintain hematocrit (Hct) > 24%. Rotational thromboelastometry (ROTEM) was performed at seven time points. All animals achieved adequate flow with a patent circuit throughout the run (pre- and post-oxygenator pressure gradient <10 mmHg). There was slow but significant hemorrhage at cannulation, arterial line, and bladder catheter sites. All animals required the maximum blood transfusion volume available. All animals became anemic after exhaustion of blood for transfusion. ABG showed progressively declining Hct and adequate oxygenation. ROTEM demonstrated decreasing fibrin-only ROTEM (FIBTEM) clot firmness. Histology was overall unremarkable. Pediatric swine are an important model for the study of pediatric ECMO. We have demonstrated the feasibility of such a model while providing descriptions of physiologic, hematologic, and coagulation parameters throughout. Weak whole-blood clot firmness by ROTEM suggested defects in fibrinogen, and there was a clinical bleeding tendency in all animals studied. This model serves as an important means to study the complex derangements in hemostasis during ECMO. © Copyright 2020 AMSECT.

Entities:  

Keywords:  ECMO; animal model; coagulopathy; transfusion

Mesh:

Year:  2020        PMID: 32981958      PMCID: PMC7499218          DOI: 10.1182/ject-2000011

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  34 in total

1.  Fibrin Network Changes in Neonates after Cardiopulmonary Bypass.

Authors:  Ashley C Brown; Riley T Hannan; Lucas H Timmins; Janet D Fernandez; Thomas H Barker; Nina A Guzzetta
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

2.  Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxinemia.

Authors:  Herbert Schöchl; Cristina Solomon; Arthur Schulz; Wolfgang Voelckel; Alexander Hanke; Martijn Van Griensven; Heinz Redl; Soheyl Bahrami
Journal:  Mol Med       Date:  2010-12-14       Impact factor: 6.354

3.  Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood.

Authors:  Corinna Velik-Salchner; Christian Schnürer; Dietmar Fries; Peter R Müssigang; Patrizia L Moser; Werner Streif; Christian Kolbitsch; Ingo H Lorenz
Journal:  Thromb Res       Date:  2005-06-27       Impact factor: 3.944

4.  Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry.

Authors:  David K Werho; Sara K Pasquali; Sunkyung Yu; Janet Donohue; Gail M Annich; Ravi R Thiagarajan; Jennifer C Hirsch-Romano; Michael G Gaies
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

5.  Hypercoagulability in centenarians: the paradox of successful aging.

Authors:  D Mari; P M Mannucci; R Coppola; B Bottasso; K A Bauer; R D Rosenberg
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

6.  Rapid ventricular pacing in pigs: an experimental model of congestive heart failure.

Authors:  E Chow; J C Woodard; D J Farrar
Journal:  Am J Physiol       Date:  1990-05

7.  Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study.

Authors:  R H Bartlett; D W Roloff; R G Cornell; A F Andrews; P W Dillon; J B Zwischenberger
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

8.  The impact of leukoreduced red blood cell transfusion on mortality of neonates undergoing extracorporeal membrane oxygenation.

Authors:  Hope T Jackson; Tolulope A Oyetunji; Alexandra Thomas; Aderonke O Oyetunji; Miller Hamrick; Evan P Nadler; Edward Wong; Faisal G Qureshi
Journal:  J Surg Res       Date:  2014-06-12       Impact factor: 2.192

9.  Effect of the Pulsatile Extracorporeal Membrane Oxygenation on Hemodynamic Energy and Systemic Microcirculation in a Piglet Model of Acute Cardiac Failure.

Authors:  Hideshi Itoh; Shingo Ichiba; Yoshihito Ujike; Takuma Douguchi; Hideaki Obata; Syuji Inamori; Tatsuo Iwasaki; Shingo Kasahara; Shunji Sano; Akif Ündar
Journal:  Artif Organs       Date:  2015-11-03       Impact factor: 3.094

10.  RBC Transfusion Practice in Pediatric Extracorporeal Membrane Oxygenation Support.

Authors:  Jennifer A Muszynski; Ron W Reeder; Mark W Hall; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; Kathleen L Meert; J Michael Dean; Tammara Jenkins; Robert F Tamburro; Heidi J Dalton
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

View more
  1 in total

1.  Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO.

Authors:  Christopher R Reed; Desiree Bonadonna; James C Otto; Charles Griffin McDaniel; Charlene Vongai Chabata; Maragatha Kuchibhatla; James Frederiksen; Juliana M Layzer; Gowthami M Arepally; Bruce A Sullenger; Elisabeth T Tracy
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-11       Impact factor: 8.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.